Post by LTS Lohmann Therapie-Systeme AG

Our colleague Frank Theobald has been invited to speak at the CRS 2026 Annual Meeting & Exposition in Lisbon, Portugal (July 6–9, 2026). In the session “Skin & Mucosal Delivery” on July 7, he will present: “Dissolvable Microneedle Array Patches at Scale – From Laboratory Feasibility to Commercial GMP Manufacturing.” At LTS, we are driving the advancement of Microneedle Array Patch (MAP) technologies beyond early-stage development—focusing on what truly matters: scalability, robustness, and GMP-ready manufacturing. As the field continues to evolve, translating innovation into reliable, commercial solutions is key to unlocking the full potential of microneedle-based drug delivery. Being recognized by CRS—one of the leading global platforms for drug delivery science—highlights the impact of our work in bridging industrial expertise and translational application. Frank is looking forward to connecting with the community in Lisbon and to discussing the future of our AccuTip MAP technology! #lts #CRS2026 #DrugDelivery #Microneedles #MAP #GMP #Innovation #DrugDeliverySystems